Meet Our Team - Glaucoma Research Foundation

Board of Directors

Board Officers

Thomas M. Brunner

Thomas M. Brunner

President and CEO

San Francisco, CA

Rick Halprin, Cpa

Rick Halprin, CPA

Director of Professional Affairs (Retired) Colleyville, TX

Andrew Iwach, Md

Andrew Iwach, MD

Executive Director, Glaucoma Center of San Francisco, San Francisco, CA

Ruth D. Williams, Md

Ruth D. Williams, MD

Wheaton Eye Clinic, Wheaton, IL

Charles Wilmoth

Charles Wilmoth

Senior Vice President–Portfolio Manager, Morgan Stanley Wealth Management, San Francisco, CA

Board Directors

Fred H. Brinkmann

Fred H. Brinkmann

Director, Information Technology (retired), Santa Rosa, CA

John G. Flanagan, Phd, Dsc, Fcoptom

John G. Flanagan, PhD, DSc, FCOptom

Dean, School of Optometry, and Professor of Optometry and Vision Science, University of California, Berkeley

Nancy S. Forster

Nancy S. Forster

Retired Consultant, Forster & Associates Consulting, LLC, San Francisco, CA

Adrienne Graves, Phd

Adrienne Graves, PhD

Chairman, Retinal Degeneration Fund; Board of Directors, GRF, Harrow, Inc., Implandata, JelliSee, Nicox, NVasc, Ocular Therapeutix, Opus Genetics, Surface Ophthalmics, Qlaris Bio, and TherOptix, San Francisco, CA

Linda Linck

Linda Linck

Delta Gamma Foundation, Lafayette, CA

Terri-Diann Pickering, Md

Terri-Diann Pickering, MD

Glaucoma Center of San Francisco, San Francisco, CA

Dennis E. Singleton

Dennis E. Singleton

Spieker Partners, Menlo Park, CA

Oluwatosin U. Smith, Md

Oluwatosin U. Smith, MD

Glaucoma Associates of Texas, Dallas, TX

Robert L. Stamper, Md

Robert L. Stamper, MD

Distinguished Professor of Clinical Ophthalmology and Director Emeritus of the Glaucoma Service, University of California, San Francisco, CA

Tracy Valorie

Tracy M. Valorie, BS, MBA

Strategic Business Consultant and Owner, TMV Associates LLC

Staff

Scientific Advisors

Catalyst for a Cure Advisory Board: Initiative to Prevent and Cure Neurodegeneration

Guojun Bu, Phd

Guojun Bu, PhD

Chief Scientific Officer, SciNeuro Pharmaceuticals Editor-in-Chief, Molecular Neurodegeneration

Adriana Di Polo, Phd

Adriana Di Polo, PhD

University of Montreal, Montreal, Quebec, Canada

Shane Liddelow, Phd

Shane Liddelow, PhD

Departments of Neuroscience and Ophthalmology NYU Langone Health, New York

Sally Temple, Phd

Sally Temple, PhD

New York Neural Stem Cell Institute University at Albany, New York

Monica L. Vetter, Phd

Monica L. Vetter, PhD

Professor and Chair, Department of Neurobiology & Anatomy, University of Utah School of Medicine

Catalyst for a Cure Advisory Board: Vision Restoration Initiative

Larry Benowitz, Phd

Larry Benowitz, PhD

Harvard Medical School, Boston Children’s Hospital, Boston, MA

Valeria Canto-Soler, Phd

Valeria Canto-Soler, PhD

University of Colorado School of Medicine, Denver, CO

Jeffrey L. Goldberg, Md, Phd

Jeffrey L. Goldberg, MD, PhD

Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA

Zhigang He, Phd, Bm

Zhigang He, PhD, BM

Harvard Medical School, Boston Children’s Hospital, Boston, MA

Shaffer Grant Advisory Committee

George A. Cioffi, Md

George A. Cioffi, MD

Columbia University College of Physicians and Surgeons, New York, NY

Adriana Di Polo, Phd

Adriana Di Polo, PhD

University of Montreal, Montreal, Quebec, Canada

Brad Fortune, Od, Phd

Brad Fortune, OD, PhD

Devers Eye Institute, Legacy Research Institute, Portland, OR

David S. Friedman, Md, Mph, Phd

David S. Friedman, MD, MPH, PhD

Massachusetts Eye and Ear, Harvard Medical School, Boston, MA

Christopher A. Girkin, Md

Christopher A. Girkin, MD

University of Alabama at Birmingham, Callahan Eye Foundation Hospital, Birmingham, AL

Jeff Gross, Phd

Jeff Gross, PhD

Department of Molecular Biosciences, University of Texas at Austin

Steven L. Mansberger, Md, Mph

Steven L. Mansberger, MD, MPH

Devers Eye Institute, Legacy Health, Portland, OR

Felipe A. Medeiros, Md Phd

Felipe A. Medeiros, MD PhD

Duke University, Durham, NC

Jason Meyer

Jason S. Meyer, PhD

Stark Neurosciences Research Institute, Indiana University School of Medicine Indianapolis, IN

Ahmara Gibbons Ross, Md, Phd

Ahmara Gibbons Ross, MD, PhD

University of Pennsylvania, Scheie Eye Institute, Philadelphia, PA

Joel S. Schuman, Md, Facs

Joel S. Schuman, MD, FACS

Professor of Ophthalmology, Kenneth L. Roper, MD Endowed Chair; Vice Chair for Research Innovation, Vickie and Jack Farber Vision Research Center; Co-Director, Glaucoma Service, Wills Eye Hospital

W. Daniel Stamer, Phd, Farvo

W. Daniel Stamer, PhD, FARVO

Duke University, Durham, NC

Ernst R. Tamm, Md

Ernst R. Tamm, MD

University of Regensburg, Regensburg, Germany

Janey L. Wiggs, Md, Phd

Janey L. Wiggs, MD, PhD

Massachusetts Eye and Ear, Harvard Medical School, Boston, MA

Monica L. Vetter, Phd

Monica L. Vetter, PhD

Professor and Chair, Department of Neurobiology & Anatomy, University of Utah School of Medicine

Honorary Advisory Board

Honorary Advisory Board

F. T. Barr

F. T. Barr

President and Founder, Afex International, Inc. Houston, Texas GRF Board Emeritus 2003-2009

June Behrendt Otto

June Behrendt Otto

Executive Director, The Edward J. Daly Foundation San Francisco, California GRF Board Emeritus 2001-2010

Sarah Brown

Sarah Brown

San Francisco, California GRF Board Emeritus 1989-1995

Steven Kirsch

Steven Kirsch

Philanthropist and Entrepreneur San Jose, California

Roger Mcguinn

Roger McGuinn

Singer-Guitarist, Co-founder of The Byrds Windemere, Florida

David E. I. Pyott

David E. I. Pyott

Former Chairman and CEO of Allergan, Inc. Irvine, California

Cary R. Rayment

Cary R. Rayment

Alcon, Inc. (retired) Cle Elum, WA

Mona Zander

Mona Zander

Hailey, Idaho GRF Board Emeritus 2009-2018

Founders